FedEx has highlighted the need for more integrated, intelligent and sustainable pharmaceutical logistics networks in Asi...
Hillhurst Bio has dosed the first subject in its Phase 2a clinical trial evaluating HBI-002 for the treatment of Parkins...
Neurocrine Biosciences has presented the first retrospective case series of CRENESSITY in patients with classic congenit...
Minghui Pharmaceutical has presented complete Phase I/II clinical data for MHB018A, a subcutaneous anti-IGF-1R antibody ...
Lundbeck has presented preliminary Phase II Part A data for asedebart, an investigational anti-adrenocorticotropic hormo...
CARsgen Therapeutics has presented new clinical data for two allogeneic CAR-T cell therapy candidates, CT0596 and CT1190...
Rznomics has presented interim Phase 1/2a clinical data for RZ-001, its RNA editing-based anticancer gene therapy for re...
Genentech has received U.S. FDA acceptance and Priority Review for its New Drug Application for giredestrant as an adjuv...
Nuvalent has received U.S. FDA acceptance and Priority Review for its New Drug Application for neladalkib in tyrosine ki...
Sanofi has received European Commission approval for subcutaneous Sarclisa, or isatuximab, in combination with standard-...
MEDIPOST has secured FDA agreement to conduct a single pivotal Phase III study for CARTISTEM in the US, marking an impor...
Pfizer has received US FDA approval for an expanded indication of Hympavzi for hemophilia A or B, broadening its use to ...
Eli Lilly has reported detailed Phase III results from three ACHIEVE trials evaluating Foundayo, or orforglipron, an ora...
Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...
Otsuka has reported positive interim Phase III VISIONARY data showing that VOYXACT preserved kidney function over 12 mon...
Hansa Biopharma has reported positive topline results from a European post-authorisation efficacy study of Idefirix in h...
SGS has acquired CMIC, INC., a specialised bioanalytical testing services provider based in Chicago, Illinois, strengthe...
Johnson & Johnson has received US FDA approval for a supplemental Biologics License Application to include evidence ...
Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...
Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond ...
Japanese startup Precision Medicine Asia (PREMIA) and US-based Lind have announced the formation of ...
Nutraceutical ingredients innovator SUANNUTRA USA has inked a distribution agreement with Spanish biotech company Fitopl...
Healthcare systems across Asia-Pacific are entering a new phase of digital transformation, as hospitals face rising pres...
Expecto Health Science, a full-service Asia-Pacific Contract Research Organization (CRO), announced a strategic pa...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
